Comparison of urine collection methods for evaluating urinary nuclear matrix protein, NMP22, as a tumor marker.

@article{Chen1997ComparisonOU,
  title={Comparison of urine collection methods for evaluating urinary nuclear matrix protein, NMP22, as a tumor marker.},
  author={Yi Ting Chen and Col Dennis L Hayden and K J Marchand and Robert W. Makuch},
  journal={The Journal of urology},
  year={1997},
  volume={158 5},
  pages={1899-901}
}
PURPOSE The nuclear matrix protein, NMP22, has been shown to be a useful tumor marker for identifying patients with a high likelihood of rapid recurrence of transitional cell carcinoma of the urinary tract after surgical treatment. Currently measurement of NMP22 involves 3 urine voids collected during a 24-hour period, which are pooled and assayed as a single sample. This study was performed to determine whether any single void would yield similar results to the pooled 3-void sample… CONTINUE READING